A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease | MicrobiomeTrials← Back to trialsNCT07211776
A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2025-12-05Est. Completion: 2027-03-14
Enrollment target: 108 participants Locations- Site01006, Beijing, China
- Site01009, Beijing, China
- Site01010, Beijing, China
- Site01029, Bengbu, China
- Site01020, Changsha, China
- Site01022, Chengdu, China
- Site01031, Chongqing, China
- Site01011, Dalian, China
- Site01008, Foshan, China
- Site01004, Fuzhou, China
- Site01007, Guangzhou, China
- Site01027, Guiyang, China
- Site01018, Hangzhou, China
- Site01002, Hefei, China
- Site01024, Jinan, China
- Site01005, Luoyang, China
- Site01017, Nanchang, China
- Site01001, Shanghai, China
- Site01012, Shenyang, China
- Site01023, Taiyuan, China
- Site01013, Tianjin, China
- Site01016, Wuxi, China
- Site01028, Xi'an, China
- Site01026, Yangzhou, China
Other microbiome trials you might be interested in
Graves' OrbitopathyThyroid Eye Disease, TEDGraves' Disease
The aim of this observational study is to investigate why some people with newly diagnosed Graves' disease (GD) develop …
Herlev, DenmarkEst. completion Aug 31, 2028
Thyroid Eye Disease
This trial will evaluate the effects of Lu AG22515 in adult men and women with moderate-to-severe thyroid eye disease (T…
Banja Luka, Bosnia and HerzegovinaEst. completion Mar 17, 2026
Site01019, Zhengzhou, ChinaSite01030, Zhengzhou, China